Tilarginine Acetate Injection intravenous infusion

TERMINATED · PHASE3 · Shock, Cardiogenic

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.